Top

Studies

Study type

Area

Group

Type of transplant

Text

Outcome after allogeneic SCT for MLL-PTD AML

Principal investigator

Marta Pratcorona

Prevalence and outcome of central nervous system (CNS) relapse after allogeneic stem cell transplantation (HSCT) in patients suffering from acute myeloid leukaemia (AML) and acute lymphoblastic leukaemia (ALL)

Principal investigator

Sabine BLUM , Yves Chalandon

Efficacy and Toxicity of ponatinib and 2nd generation TKI given after allogeneic SCT in Ph+ adult ALL.

Principal investigator

Klaus HIRSCHBUEHL

Elderly AML: A randomised Phase III study comparing conventional chemotherapy to low dose total body irradiation-based conditioning and hematopoietic stem cell transplantation from related and unrelated donors as consolidation therapy for older patients with AML in 1st complete remission

Type of transplant

Principal investigator

Dietger Niederwieser

Need help?

First Name

Last Name

Email address

CIC number

Area of interest

Message box

I understand and accept that my personal data will be used for communication concerning the submitted query or request.

The personal data provided will be processed according to the General Data Protection Regulation (GDPR 2016/679 ) and incorporated to a file property of EBMT which will be allocated in the EEA (European Economic Area) or in countries that are provided with the same level of protection for privacy such as countries that adhere to EU-US and Swiss-US Privacy Shield Frameworks.
Data Subjects have the right of access to his or her data and the right to rectification of any inaccurate or incomplete personal data. The Data Subject also has the right to withdraw consent, this wish will be respected, and the personal will no longer be made available. If the processing operation is unlawful the Data Subject has the right to request deletion of that data. Please write to data.protection@ebmt.org